top of page
  • Facebook
  • White Twitter Icon
  • Soundcloud
  • White Instagram Icon
  • LinkedIn
  • TikTok

Cannabis for Anxiety: Cannabinoids for Childhood Psychiatric Disorders

Welcome to homework assignment CAS 1.10 in the Cannabis for Anxiety seminar from Higher Learning LV. This assignment focuses on the therapeutic application of cannabis for anxiety and, specifically, a 2023 study about the potential efficacy of cannabinoids for childhood neurodevelopmental and neuropsychiatric disorders, including a number of anxiety disorders.


After you complete this assignment, use the button at the bottom to return to the Cannabis for Anxiety seminar master page.

A 2023 Australian study entitled "Efficacy of Cannabinoids in Neurodevelopmental and Neuropsychiatric Disorders Among Children and Adolescents: A Systematic Review" that was published in the journal European Child & Adolescent Psychiatry provided a "systematic review of the rationale and current clinical trial evidence for cannabinoid-based products (CBPs) in the treatment of neuropsychiatric and neurodevelopmental disorders in children and adolescents."

Want to read more?

Subscribe to curtarobbins.wixsite.com to keep reading this exclusive post.

Higher Learning LV

There are many ways to learn from us, including 👇🏽

Teaching the Commerce + Chemistry of Cannabis™

Did You Know?

The cannabis genome produces 100+ cannabinoids, 150+ terpenes, and 20 flavonoids.

These phytomolecules interact with the human endocannabinoid system (ECS) to produce wellness.

But it gets complex. Biphasic response curves, biosynthetic pathways, and acidic precursors all commingle. Subscribe to learn how. 

Copyright © 2023 Higher Learning LV. All Rights Reserved. Unauthorized reuse strictly prohibited.

bottom of page